Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 4Genitourinary 2Dermatologic 2Thoracic 1Other 1CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 12Small Cell Lung Carcinoma 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Mesothelioma 2Thymoma 1Somatostatinoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Insulinoma 1Hereditary Sensory and Autonomic Neuropathies 1Glucagonoma 1Gastrointestinal Neoplasms 1Gastrinoma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Large Cell 1Carcinoma, Islet Cell 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Trastuzumab 2vatalanib 1tipifarnib 1pentetreotide 1Thalidomide 1Oxaliplatin 1Leucovorin 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1Fluorouracil 1Fentanyl 1Everolimus 1Bevacizumab 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulinoma × Everolimus × Thoracic × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡